MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RETA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Reata Pharmaceuticals (RETA) Ownership - Who owns Reata Pharmaceuticals?

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
5320 Legacy Drive
Phone
+1 972 865-2219
Employees
323
Web
https://www.reatapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.57B
P/E Ratio
N/A
Total Cash
330.21M
Projected Growth
N/A
Total Debt
166M
Revenue
23.48M
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash/Share
8.67
Total Debt/Equity
N/A
Revenue/Share
0.61 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RETA
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for treatment of inflammatory diseases and cancer

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
5320 Legacy Drive
Phone
+1 972 865-2219
Employees
323
Web
https://www.reatapharma.com